Compare Invesco DB Oil Fund (DBO) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco DB Oil Fund vs Humana Inc — how do they compare? Invesco DB Oil Fund trades at $24.13 (market cap $255.13M), while Humana Inc trades at $431.03 (market cap $46.49B). The key difference: Humana Inc is far larger — about 182.2× Invesco DB Oil Fund's market cap, and Humana Inc pays a 0.91% dividend while Invesco DB Oil Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Invesco DB Oil Fund for 31 Days and Humana Inc for 51 Days on average.
| DBO | HUM | |
|---|---|---|
Market Cap | $255.13M | $46.49B |
Volume | 562,167 | 2,567,704 |
Sector | Commodities - Energy | Health |
52-Week High | $26.35 | $431.03 |
52-Week Low | $11.98 | $163.67 |
Typical Hold Time | 31 Days | 51 Days |
Enterprise Value | — | $53.84B |
Dividend Yield | — | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DBO trades at $24.13, up 2.51% today amid mixed oil market signals. Technical indicators show a neutral overall signal with bearish moving averages, while oscillators remain neutral. Recent news highlights Middle East supply disruptions and OPEC+ production decisions creating volatility in energy markets. The stock faces resistance at $24 and support at $23 levels.
The outlook remains uncertain with geopolitical tensions supporting oil prices but strategic reserve releases creating downward pressure. Key risks include supply chain disruptions and regulatory challenges, while institutional sentiment appears cautious given the mixed technical signals and market volatility.
Humana (HUM) trades at $387.12, down 2.37% today, with a bullish technical outlook supported by moving averages and strong institutional interest. The company shows steady revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent analyst upgrades and a $460.74 consensus price target suggest upside potential, while Medicare Advantage plan changes and fiduciary scrutiny present near-term headwinds.
The stock offers value with a low P/S ratio of 0.32x and consistent earnings beats, but faces margin pressure and regulatory risks. Institutional accumulation and positive technicals support a constructive outlook, though investors should monitor enrollment trends and cost management execution for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco DB Oil Fund
DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
